{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-087243","form_type":"8-K","ticker":"MOVE","cik":"0001734750","company_name":"Corvex, Inc.","filed_at":"2023-11-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.258392+00:00","generated_at":"2026-06-08T02:36:27.246001+00:00","sec_items":["2.02","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Movano Health to launch Evie Ring Nov 20; reports Q3 net loss $9.0M","bullets":["Evie Ring launches Nov 20 at $269 with no subscription; shipping expected by year-end.","Blood pressure SoC met FDA accuracy standards in clinical study; pivotal trial planned.","FDA requested additional info on Evie Ring pulse oximeter 510(k); reply planned Q1 2024.","Priced $3.6M public offering of 4.2M shares at $0.85; expected close Nov 17.","Q3 net loss $9.0M ($0.18 loss per share); no revenue; pro forma cash $10.8M."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-087243","json":"https://secwatch.observer/filing/0001213900-23-087243.json","markdown":"https://secwatch.observer/filing/0001213900-23-087243.md","text":"https://secwatch.observer/filing/0001213900-23-087243.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1734750/000121390023087243/0001213900-23-087243-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1734750/000121390023087243/ea188087-8k_movanoinc.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T02:36:27.246001+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"485e1dde29210b6a3d8f669092b5b2b460cbef10","claim":"Corvex, Inc. reported the three months ending September 30, 2023 results: net income $9.0 million, EPS $(0.18) per basic and diluted share.","evidence_excerpt":"Movano Health reported a net loss of $9.0 million and a loss of $(0.18) per basic and diluted share, in the third quarter of 2023","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1734750/000121390023087243/0001213900-23-087243-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the three months ending September 30, 2023"},{"label":"Net income","value":"$9.0 million"},{"label":"EPS","value":"$(0.18) per basic and diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}